Reuters logo
2 months ago
BRIEF-Diamyd subscribes for an additional SEK 1 mln in nextcell ongoing new issue ahead of IPO
June 5, 2017 / 6:31 AM / 2 months ago

BRIEF-Diamyd subscribes for an additional SEK 1 mln in nextcell ongoing new issue ahead of IPO

1 Min Read

June 5 (Reuters) - DIAMYD MEDICAL AB:

* DIAMYD MEDICAL SUBSCRIBES FOR AN ADDITIONAL SEK 1 MILLION IN NEXTCELL PHARMA'S ONGOING NEW ISSUE AHEAD OF IPO

* DIAMYD MEDICAL'S OWNERSHIP IN NCP BEFORE NEW ISSUE AMOUNTS TO APPROXIMATELY 16 % AND IS EXPECTED TO BE APPROXIMATELY 12 % AFTER A FULLY SUBSCRIBED NEW ISSUE

* DIAMYD MEDICAL SUBSCRIBES FOR AN ADDITIONAL SEK 1 MILLION IN NEXTCELL PHARMA'S ONGOING NEW ISSUE AHEAD OF IPO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below